FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Post Timely De Novo Summaries: Law Firm

A Hyman, Phelps & McNamara medical device regulatory expert and attorney say FDA needs to improve the timeliness of its posting of de novo decision su...

latest-news-card-1
Medical Devices

ICU Medical Expands Class 1 Recall of Infusion Pumps

ICU Medical expands a Class 1 recall of its Plum 360, Plum A+ and Plum A+3 Infusion Systems to update the use instructions due to a manufacturing defe...

latest-news-card-1
Human Drugs

Transplant Drug Gets Orphan/Fast Track Status

FDA grants ReAlta Life Sciences orphan drug and fast track designations for RLS-0071 and its use in treating hospitalized patients with steroid-refrac...

latest-news-card-1
Federal Register

Pennsaid Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that Horizon Therapeutics Pennsaid (diclofenac sodium) topical solution 2% was not withdrawn due to safety or ...

latest-news-card-1
Federal Register

ANDA Product-Specific Meeting Request Guide

Federal Register notice: FDA makes available a final guidance entitled Product-Specific Guidance Meetings Between FDA and ANDA Applicants Under GDUFA....

latest-news-card-1
Biologics

J&J Combo Approved for Lung Cancer

FDA approves a Johnson & Johnson BLA for Rybrevant (amivantamab-vmjw) plus Lazcluze (lazertinib) for the first-line treatment of certain adult patient...

latest-news-card-1
Medical Devices

FDA Clears SI-Bone Pelvic Fracture Implant

FDA clears a SI-Bone 510(k) for the iFuse Torq TNT Implant System for pelvic fragility fracture fixation and sacroiliac joint fusion.

Medical Devices

SoClean CPAP Disinfecting Device Authorized

CDRH grants a de novo marketing authorization for SoCleans 3+ Bacterial Reduction Device, an over-the-counter product intended to be used as an adjunc...

latest-news-card-1
Human Drugs

Enhertu Given Breakthrough Status in Breast Cancer

FDA grants Daiichi Sankyo and AstraZeneca a breakthrough therapy designation for Enhertu (fam-trastuzumab deruxtecan-nxki) for treating certain unrese...

latest-news-card-1
Human Drugs

Hold Lifted on Lung/Breast Cancer ADC Drug

FDA lifts a partial clinical hold on a MediLink Therapeutics and BioNTech Phase 1 trial evaluating BNT326/YL202 (NCT05653752), a HER3-targeted antibod...